These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24886600)

  • 21. Gene Polymorphisms in the RANKL/RANK/OPG Pathway Are Associated with Type 2 Diabetes Mellitus in Southern Han Chinese Women.
    Duan P; Tu P; Si L; Hu W; Liu M; Liu J; Xue Y
    Genet Test Mol Biomarkers; 2016 Jun; 20(6):285-90. PubMed ID: 27171030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis.
    Skoumal M; Kolarz G; Haberhauer G; Woloszczuk W; Hawa G; Klingler A
    Rheumatol Int; 2005 Nov; 26(1):63-9. PubMed ID: 15889303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
    Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
    Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study.
    Assmann G; Pfoehler C; Simon P; Pfreundschuh M; Tilgen W; Wieczorek S
    J Dermatol; 2011 Jun; 38(6):519-23. PubMed ID: 21352301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphism of the OPG gene associated with breast cancer.
    Ney JT; Juhasz-Boess I; Gruenhage F; Graeber S; Bohle RM; Pfreundschuh M; Solomayer EF; Assmann G
    BMC Cancer; 2013 Jan; 13():40. PubMed ID: 23369128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
    Liu W; Zhang X
    Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis.
    Xu S; Wang Y; Lu J; Xu J
    Rheumatol Int; 2012 Nov; 32(11):3397-403. PubMed ID: 22057136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men.
    Roshandel D; Holliday KL; Pye SR; Ward KA; Boonen S; Vanderschueren D; Borghs H; Huhtaniemi IT; Adams JE; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; Thomson W; ONeill TW;
    Calcif Tissue Int; 2011 Dec; 89(6):446-55. PubMed ID: 21964949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL2RA is associated with persistence of rheumatoid arthritis.
    van Steenbergen HW; van Nies JA; Ruyssen-Witrand A; Huizinga TW; Cantagrel A; Berenbaum F; van der Helm-van Mil AH
    Arthritis Res Ther; 2015 Sep; 17(1):244. PubMed ID: 26350950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians.
    Dong SS; Liu XG; Chen Y; Guo Y; Wang L; Zhao J; Xiong DH; Xu XH; Recker RR; Deng HW
    Calcif Tissue Int; 2009 Aug; 85(2):104-12. PubMed ID: 19458885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis.
    Pettit AR; Walsh NC; Manning C; Goldring SR; Gravallese EM
    Rheumatology (Oxford); 2006 Sep; 45(9):1068-76. PubMed ID: 16490750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of OPG/RANK/RANKL Genes as a Genetic Marker for Cardiac abnormalities in Thalassemia Major Patients.
    Singh MM; Kumar R; Tewari S; Agarwal S
    Ann Hum Genet; 2017 May; 81(3):117-124. PubMed ID: 28244588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: a study in seven cohorts.
    Krabben A; Wilson AG; de Rooy DP; Zhernakova A; Brouwer E; Lindqvist E; Saxne T; Stoeken G; van Nies JA; Knevel R; Huizinga TW; Toes R; Gregersen PK; van der Helm-van Mil AH
    Arthritis Rheum; 2013 Dec; 65(12):3051-7. PubMed ID: 23983153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SNPs in the vicinity of P2X7R, RANK/RANKL/OPG and Wnt signalling pathways and their association with bone phenotypes in academy footballers.
    Varley I; Hughes DC; Greeves JP; Fraser WD; Sale C
    Bone; 2018 Mar; 108():179-185. PubMed ID: 29325759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone Remodeling and Bone Structural Genes in Legg-Calvé-Perthes Disease: The
    Cruz-Ortíz BL; Hernández-Zamora E; Reyes-Maldonado E; Rodríguez-Olivas AO; Rubio-Lightbourn J; Martínez-Ramírez CO; Castro-Hernández C; Lezama-Palacios R; Casas-Avila L
    DNA Cell Biol; 2024 Jun; 43(6):288-297. PubMed ID: 38648538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).
    Pereira RMR; Figueiredo CP; Cha CC; Caparbo VF; Oliveira RM; Franco AS; Menezes PR; de Castro I; Onuchic LF
    Osteoporos Int; 2016 Nov; 27(11):3319-3329. PubMed ID: 27311721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RANKL/RANK/OPG Polymorphisms and Heel Quantitative Ultrasound in Young Adults.
    Correa-Rodríguez M; Schmidt-RioValle J; Rueda-Medina B
    Nurs Res; 2017; 66(2):145-151. PubMed ID: 28252575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.
    Bonfá AC; Seguro LP; Caparbo V; Bonfá E; Pereira RM
    Osteoporos Int; 2015 May; 26(5):1563-71. PubMed ID: 25609157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
    Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils.
    Poubelle PE; Chakravarti A; Fernandes MJ; Doiron K; Marceau AA
    Arthritis Res Ther; 2007; 9(2):R25. PubMed ID: 17341304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.